Description

Lazolvan Tablets 30 mg. №20

Ingredients

Active ingredient: Ambroxol hydrochloride 30 mg per tablet.

Dosage

Recommended dosage: Take 1 tablet orally three times a day. Do not exceed the recommended dose.

Indications

Lazolvan tablets 30 mg. №20 are indicated for the treatment of respiratory conditions associated with excessive mucus production, such as acute and chronic bronchitis, bronchiectasis, and asthma.

Contraindications

Do not use Lazolvan tablets 30 mg. №20 if:

• You are allergic to Ambroxol or any other ingredients in the tablets.
• You have a history of hypersensitivity reactions to mucolytic agents.
• You are in the first trimester of pregnancy.

Directions

How to take Lazolvan tablets 30 mg. №20:

• Swallow the tablets whole with a glass of water.
• Take the tablets with or without food as directed by your healthcare provider.
• Do not crush or chew the tablets.

Scientific Evidence

Ambroxol, the active ingredient in Lazolvan tablets, has been extensively studied for its mucolytic and expectorant properties. Research has shown that Ambroxol helps to reduce the viscosity of mucus in the respiratory tract, making it easier to cough up and clear the airways. Studies have also demonstrated the effectiveness of Ambroxol in improving lung function and reducing symptoms in patients with respiratory conditions.

Clinical trials have highlighted the efficacy of Lazolvan tablets 30 mg. №20 in improving mucus clearance and reducing cough frequency in patients with bronchitis and other respiratory disorders. Patients treated with Ambroxol showed significant improvements in their respiratory symptoms compared to those receiving a placebo, indicating the therapeutic benefits of Lazolvan tablets.